Harmonization of immunotoxicity guidelines in the ICH process – pathology considerations from the Guideline Committee of the European Society of Toxicological Pathology (ESTP)
- 1 August 2005
- journal article
- Published by Elsevier BV in Experimental and Toxicologic Pathology
- Vol. 57 (1), 1-5
- https://doi.org/10.1016/j.etp.2005.03.001
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Accuracy of Extended Histopathology to Detect Immunotoxic ChemicalsToxicological Sciences, 2004
- Extended Histopathology in Immunotoxicity Testing: Interlaboratory Validation StudiesToxicological Sciences, 2004
- A Brief History of Immunotoxicology and a Review of the Pharmaceutical GuidelinesInternational Journal of Toxicology, 2004
- Implications of the new FDA/CDER immunotoxicology guidance for drugs.International Immunopharmacology, 2002
- Immune Responses: Adverse Versus Non-Adverse EffectsToxicologic Pathology, 2002
- US FDA "Redbook II" Immunotoxicity Testing Guidelines and Research in Immunotoxicity Evaluations of Food Chemicals and New Food ProteinsToxicologic Pathology, 2000
- Approaches to the identification and recording of findings in the lymphoreticular organs indicative for immunotoxicity in regulatory type toxicity studies.Toxicology, 1999
- Immunotoxicology assessment in the pharmaceutical industryToxicology Letters, 1998
- Report of validation study of assessment of direct immunotoxicity in the ratToxicology, 1998
- Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicologyFood and Chemical Toxicology, 1995